| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 34,908 | 32,403 | 33,461 | 37,670 | | Cost of Revenue | 19,057 | 16,665 | 18,464 | 21,994 | | | Gross Profit | 15,851 | 15,738 | 14,997 | 15,676 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 5,817 | 5,406 | 5,156 | 6,198 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 5,340 | 5,043 | 5,283 | 5,372 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 4,694 | 5,289 | 4,558 | 4,106 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 14 | 32 | 9 | 12 | | Earnings Before Interest And Taxes | 4,708 | 5,321 | 4,567 | 4,118 | | Interest Expense | 1,728 | 1,719 | 1,708 | 1,821 | | Income Before Tax | 2,980 | 3,602 | 2,859 | 2,297 | | Income Tax Expense | (3,126) | 1,485 | 1,233 | 618 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 6,106 | 2,117 | 1,626 | 1,679 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 6,106 | 2,117 | 1,626 | 1,679 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $6,106 | $2,117 | $1,626 | $1,679 |
|
0.16% Nasdaq 
Income Statement
